These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 21036331)
1. Genetics of the metabolic complications of obesity. Lewis JP; Shuldiner AR Prog Mol Biol Transl Sci; 2010; 94():349-72. PubMed ID: 21036331 [No Abstract] [Full Text] [Related]
2. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome. Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319 [TBL] [Abstract][Full Text] [Related]
3. [The genetics of human monogenic obesity]. Zhang CB; Wu HL Yi Chuan Xue Bao; 2004 Aug; 31(8):864-9. PubMed ID: 15481544 [TBL] [Abstract][Full Text] [Related]
4. PPAR gamma as a metabolic regulator: insights from genomics and pharmacology. Savage DB Expert Rev Mol Med; 2005 Jan; 7(1):1-16. PubMed ID: 15673477 [TBL] [Abstract][Full Text] [Related]
5. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870 [TBL] [Abstract][Full Text] [Related]
7. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women. Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844 [TBL] [Abstract][Full Text] [Related]
8. Human obesity and insulin resistance: lessons from experiments of nature. O'Rahilly S Biochem Soc Trans; 2007 Feb; 35(Pt 1):33-6. PubMed ID: 17212584 [TBL] [Abstract][Full Text] [Related]
9. Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Barbieri M; Rizzo MR; Papa M; Acampora R; De Angelis L; Olivieri F; Marchegiani F; Franceschi C; Paolisso G Exp Gerontol; 2005 Jul; 40(7):599-604. PubMed ID: 16029943 [TBL] [Abstract][Full Text] [Related]
10. [Two promising candidate genes in the ethiopathogenesis of DM2 - PPARgamma2 and KCNJ11]. Vejrazková D; Bendlová B Cas Lek Cesk; 2005; 144(11):721-5; discussion 725-6. PubMed ID: 16335696 [TBL] [Abstract][Full Text] [Related]
11. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study. Lagou V; Scott RA; Manios Y; Chen TL; Wang G; Grammatikaki E; Kortsalioudaki C; Liarigkovinos T; Moschonis G; Roma-Giannikou E; Pitsiladis YP Obesity (Silver Spring); 2008 Apr; 16(4):913-8. PubMed ID: 18379566 [TBL] [Abstract][Full Text] [Related]
13. Relationship between obesity, adipocytokines, and blood pressure: possible common genetic and environmental factors. Pantsulaia Ia; Trofimova S; Kobyliansky E; Livshits G Am J Hum Biol; 2009; 21(1):84-90. PubMed ID: 18785642 [TBL] [Abstract][Full Text] [Related]
14. [Human genetic mutations and polymorphisms of adipocytokines relating to obesity]. Hiuge A; Kihara S Nihon Rinsho; 2009 Feb; 67(2):266-9. PubMed ID: 19202898 [TBL] [Abstract][Full Text] [Related]
15. Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. Tsuda T J Agric Food Chem; 2008 Feb; 56(3):642-6. PubMed ID: 18211021 [TBL] [Abstract][Full Text] [Related]
17. Effect of the Pro12Ala polymorphism of the PPAR gamma 2 gene on response to pioglitazone treatment in menopausal women. Ramírez-Salazar M; Pérez-Luque E; Fajardo-Araujo M; Garza SM; Malacara JM Menopause; 2008; 15(6):1151-6. PubMed ID: 18551086 [TBL] [Abstract][Full Text] [Related]
18. Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder. Chen CH; Lu ML; Kuo PH; Chen PY; Chiu CC; Kao CF; Huang MC Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):239-45. PubMed ID: 21095215 [TBL] [Abstract][Full Text] [Related]
19. Role of adipokines in complications related to obesity: a review. Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356 [TBL] [Abstract][Full Text] [Related]
20. Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects. Brisson D; St-Pierre J; Santuré M; Hudson TJ; Després JP; Vohl MC; Gaudet D Int J Obes (Lond); 2007 Aug; 31(8):1325-33. PubMed ID: 17342071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]